This opens the possibility to determine if these isoforms, glycated or not, could be detected in serum, and if the fucosylation of tissular haptoglobin could help to distinguish between a healthy and a malignant tissue through the analysis of biopsies newly obtained from patients in hope of some diagnosis, whether it be in ovarian cancer or another. The gene discussed is HP; the disease is ovarian carcinoma.